What are the most important things to know about tipranavir?
Some people taking tipranavir in combination with ritonavir (a [ agent] always used with tipranavir) have had liver problems. People with a history of chronic (HBV) or (HCV) or who have elevated results on liver function tests may have an increased risk of developing new or worsening liver problems while taking tipranavir in combination with ritonavir.
Contact your health care provider right away if you have any of the following symptoms that could be signs of liver problems:
- Yellowing of your skin or the whites of your eyes ()
- Dark-colored urine
- Light-colored bowel movements
- Loss of appetite for several days or longer
- Nausea of vomiting
- Pain, aching, or tenderness on the right side of your stomach/abdominal area
Contact your health care provider right away if you develop a rash while taking tipranavir. Stop taking tipranavir and get medical help right away if you develop a rash with any of the following symptoms:
- General ill feeling
- Extreme tiredness
- Muscle or joint aches
- Blistering or peeling skin
- Blisters or sores in your mouth
- Redness or swelling of the eyes ()
- Swelling of your face, lips, mouth, tongue or throat
- Trouble breathing or swallowing
Some people taking tipranavir in combination with ritonavir may develop bleeding in the brain. Report any unusual or unexplained bleeding to your health care provider.
Taking tipranavir and ritonavir with certain other medicines may cause serious, life-threatening side effects. Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
While taking tipranavir, it is important to keep all of your appointments with your health care provider.
What is tipranavir?
Tipranavir (brand name: Aptivus) is a prescription medicine approved by the U.S. (FDA) for the treatment of HIV in adults and children 2 years of age and older who meet specific requirements, as determined by a health care provider.
Tipranavir is always used with the boosting agent ritonavir (brand name: Norvir) and other HIV medicines.
Although tipranavir is FDA-approved for use in adults and children, it is no longer commonly used or recommended as an HIV treatment. The Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV and the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection no longer contain detailed or updated information on the use of tipranavir. Please refer to the FDA drug label for additional information regarding the use of tipranavir in people with HIV.
HIV medicines cannot cure HIV/AIDS, but taking HIV medicines every day helps people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV . If you are taking HIV medicines, do not cut down on, skip, or stop taking them unless your health care provider tells you to.
What should I tell my health care provider before taking tipranavir?
Before taking tipranavir, tell your health care provider:
- If you are allergic to tipranavir, sulfonamides (), or any other medicines.
- If you have or another medical condition that increases your risk of bleeding, including trauma or surgery.
- If you are taking medicines that increase your risk of bleeding.
- If you have problems, including (HBV) or (HCV).
- If you have high or high .
- If you have .
- If you have any other medical conditions.
- If you are pregnant or plan to become pregnant. Talk to your health care provider about the risks and benefits of taking tipranavir during pregnancy. For more information on the use of tipranavir during pregnancy, please refer to the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States.
- If you are breast/chestfeeding or plan to breast/chestfeed. For people with HIV in the United States, the Guideline recommends speaking with your health care provider to discuss options for feeding your baby. People with suppressed have a less than 1% chance of transmitting HIV to their baby via their own milk.
- If you are using -based birth control (such as pills, , or vaginal rings). Tipranavir may make these forms of birth control less effective. In addition, there may be an increased risk of rash when tipranavir is taken with birth control pills. Your health care provider may recommend that you use additional or alternative forms of birth control while you are taking tipranavir. For more information about using birth control and HIV medicines at the same time, view the HIVinfo HIV and Birth Control infographic.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products (particularly St. John's wort) you are taking or plan to take. Tipranavir may affect the way other medicines or products work, and other medicines or products may affect how tipranavir works. Taking tipranavir together with certain medicines or products may cause serious, life-threatening side effects.
How should I take tipranavir?
Tipranavir comes in the following forms and strengths:
- 250-mg capsules
- 100-mg/mL oral solution
Take tipranavir according to your health care provider’s instructions. Do not miss a of tipranavir, and do not change your dose or stop taking tipranavir without first talking with your health care provider.
Tipranavir is always taken with the agent ritonavir. Take tipranavir and ritonavir by mouth at the same time. If you are taking tipranavir with ritonavir oral solution, the medicines can be taken with or without meals. If you are taking tipranavir with ritonavir tablets, the medicines must be taken with meals.
Tipranavir capsules should be swallowed whole. Do not open or chew the capsules.
Always take tipranavir and ritonavir in combination with other HIV medicines.
The oral solution of tipranavir contains vitamin E. If you take tipranavir oral solution, you can take a standard multivitamin, but do not take any other vitamin E supplements. Taking too much vitamin E during treatment with tipranavir may increase your risk of developing bleeding problems.
If you have taken too much tipranavir, contact your health care provider or local poison control center (1-800-222-1222 or online) right away, or go to the nearest hospital emergency room.
For more information on how to take tipranavir, see the FDA drug label.
What should I do if I forget a dose?
If you miss a of tipranavir, take the missed dose as soon as you remember it. But if it is almost time for your next dose, skip the missed dose and just take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
What side effects can tipranavir cause?
Tipranavir may cause side effects. Some side effects of tipranavir can be serious as noted above. Many side effects from HIV medicines, such as nausea or occasional dizziness, are manageable. See the HIVinfo fact sheet on HIV Medicines and Side Effects for more information.
Other possible side effects of tipranavir include:
- Diabetes and high blood sugar ().
- Changes in body fat ().
- Changes in your (called or IRIS). IRIS is a condition that sometimes occurs when the immune system begins to recover after treatment with an HIV medicine. As the immune system gets stronger, it may have an increased response to a previously hidden .
- Increases in levels of and .
- Increased bleeding in people with .
Tell your health care provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of tipranavir. To learn more about possible side effects of tipranavir, read the drug label or or talk to your health care provider or pharmacist.
You can report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088) or online.
How should tipranavir be stored?
- Store unopened containers of tipranavir capsules in a refrigerator at 36°F to 46°F (2°C to 8°C). Store opened containers of tipranavir capsules at room temperature, 68°F to 77°F (20°C to 25°C). Once the container has been opened, the capsules must be used within 60 days.
- Store tipranavir oral solution at 59°F to 77°F (15°C to 25°C). Do not refrigerate or freeze the oral solution. Once the container has been opened, the oral solution must be used within 60 days.
- Keep tipranavir in the container that it came in and keep the container tightly closed.
- Do not use tipranavir if the original seal over the container opening is broken or missing.
- Throw away tipranavir that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep tipranavir and all medicines out of reach of children.
Where can I find more information about tipranavir?
- For more information on the use of tipranavir in people with HIV, please refer to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV and the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.
- This Patient Version drug summary is based on the following FDA label(s): Capsule (liquid filled), solution. The Patient Counseling Information section of the label includes information for people taking tipranavir.
- The American Hospital Formulary Service (AHFS) Patient Medication Information for tipranavir available from MedlinePlus.
- Tipranavir-related research studies, from ClinicalTrials.gov. (The ClinicalTrials.gov search can be modified so that you can get results that better match your interests.)
- A list of FDA-approved HIV medicines, from HIVinfo.
Main number: 800-243-0127
Patient assistance: 800-556-8317
Last Reviewed: December 15, 2023